Thanks to its late-year exclusivity loss, Cialis will hold its blockbuster ground this year, EvaluatePharma figures, generating $1.28 billion in U.S. sales. Then, the coming year, the downfall starts. Cialis will post significantly lower sales in 2018’$304 million’and continue to drop beyond this concept, according to the analysts.??